SOUTH SAN FRANCISCO, CA and VANCOUVER, BC — /CNW/ — ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate… Read More
VANCOUVER, BC — Bold Therapeutics, a clinical-stage biopharmaceutical company developing first-in-class oncology therapeutics, will be presenting positive interim results in advanced gastric and biliary tract cancer at the 2023 American… Read More
EDMONTON, AB — (BUSINESS WIRE) — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced the results of a post-hoc, pooled analysis of the Phase 2 AURA-LV (NCT02141672)… Read More
VANCOUVER, BC — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced… Read More
Update on Yeast-based Precision Biopesticide Technology 2023 Plans Invitation for Joint Development Partners to Accelerate Development of Multiple Products Using Sustainable Bio-based Precision Crop Protection Technology VANCOUVER, BC — Renaissance… Read More
